LS11-006 Reinhard Kirnbauer (Medical University Vienna) Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Duration: 60 months, Funding volume: € 800,000
Reporting from older projects, calls opened before May 2022: funding.wwtf.at
All other reporting and contracting, please refer to funding.wwtf.at
JPETo™ CMS Login
Loading...
We use cookies on our website. Some of them are technically necessary, while others help us to improve this website or provide additional functionalities. Further information